SCOPE 365 | Home of the Clinical Research Resources

Home About Clinical Research News Insights Podcasts Videos SCOPE Events

DEADLINE EXTENDED! - SCOPE 365 Solve - Help Solve a Real Clinical Research Challenge

SCOPE 365 and TransCelerate Biopharma are calling for practical solutions that automate clinical data acquisition configuration using USDM digital protocols. Submit your abstract, showcase your innovation to leaders across the clinical research community, and help shape the future of study startup. Finalists will be recognized at SCOPE Europe this October. Submission deadline now extended to August 28!

Learn More & Submit Your Abstract »

Latest In Clinical Trials

The Most Valuable Clinical Trial Data May Come From Studies That Are Already Over

Insights from SCOPE | Completed clinical trials contain valuable evidence about protocol design, feasibility, site performance, patient burden, and amendments. Learn how connecting and applying historical operational data can help organizations avoid recurring problems and make stronger decisions in future studies from the outset. more...

August 20, 2026
MD Anderson: Immune System Provides Biological Blueprint for Treating Cancer-Related Depression with Psychedelics

Clinical Research News | Since the brain and body are inexorably connected and seem to modulate each other, it follows that the best way to help cancer patients suffering from depression is to view the condition holistically based on their systemic and brain biology and not just their lived experience. To that end, psychedelics like ketamine and psilocybin are actively entering the treatment paradigm. more...

August 19, 2026
Clinical Trial Protocol Complexity Is a Measurable Risk

Insights from SCOPE | Protocol complexity affects far more than study design. It shapes patient burden, site capacity, enrollment, retention, timelines, and cost. Learn how measuring complexity earlier can help teams identify operational risks, evaluate tradeoffs, and build more executable clinical trials. more...

August 18, 2026
DIOSynVax Advances Broadly Protective Vaccine Platform with Phase 1 Proof of Concept

Clinical Research News | Digital Immune-Optimized Synthetic vaccines (DIOSynVax) is betting that the future of vaccination lies not in chasing individual viral variants, but in designing broadly protective vaccines that target entire virus families. The University of Cambridge spinout is using artificial intelligence (AI), genomics, synthetic biology, and immunology to create vaccine antigens that could be delivered through a range of existing vaccine platforms, with early clinical data supporting the concept. more...

August 18, 2026
Management of Co-Occurring Conditions of Down Syndrome Becoming More Personalized

Clinical Research News | Medical conditions vary widely in presentation, progression, and treatment response, with Down syndrome standing out as one of the most variable of all. The genetic occurrence, caused by an extra copy of chromosome 21, is widely considered one of the most heterogenous conditions, with highly variable clinical presentation from person to person. more...

August 13, 2026
Why Patient Availability Is Not the Same as Patient Recruitability

Insights from SCOPE | Identifying eligible patients is only the beginning. Successful recruitment also depends on trust, access, provider engagement, study burden, and caregiver support. Learn why feasibility planning must look beyond patient availability to understand who can realistically participate. more...

August 13, 2026